Tempest Therapeutics, Inc. (TPST) › Shareholders' EquityTempest Therapeutics, Inc. (TPST) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: -$2.38M2012: $30.72M2013: $41.70M2014: $55.33M2015: $126.85M2016: $108.22M2017: -$130.69M2018: $70.95M2019: -$50.36M2020: -$68.79M2021: $36.12M2022: $18.11M2023: $26.77M2024: $19.13M2025: $6.67M$6.67M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$6.67M-65.1%2024$19.13M-28.5%2023$26.77M+47.8%2022$18.11M-49.9%2021$36.12M+152.5%2020-$68.79M-36.6%2019-$50.36M-171.0%2018$70.95M+154.3%2017-$130.69M-220.8%2016$108.22M-14.7%2015$126.85M+129.3%2014$55.33M+32.7%2013$41.70M+35.7%2012$30.72M+1392.4%2011-$2.38M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share